Podcast

January 28, 2026

224 – ICH Q2 Explained: What Analytical Validation Really Requires

In this episode of Let’s Combinate, host Subhi Saadeh breaks down the ICH Q2 guideline with a practical focus on analytical procedure validation. The discussion covers key definitions, core validation

January 21, 2026

223 – What’s Changing in ICH Q1 and What Isn’t: Understanding Stability Expectations

In this episode of Let’s Combinate: Drugs and Devices, host Subhi Saadeh breaks down the 2025 draft update to the ICH Q1 guideline and explains what has actually changed and

January 14, 2026

222 – How ICH Guidelines Are Organized: Understanding the Q, S, E, and M Series

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh continues the Combinating with ICH series by breaking down how the International Council for Harmonisation (ICH) guidelines are

January 7, 2026

221 – What Is ICH and Why It Matters

In this episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh kicks off a new series focused on the International Council for Harmonisation (ICH) and its impact on drug and

December 31, 2025

220 – Managing Oneself, Reflections and a New Series on ICH

???? Stay ahead in combination products, pharma, and medical devices ???? https://www.letscombinate.com ????️ Listen to more expert discussions on regulations, drug delivery, and quality ???? https://www.letscombinate.com/ Get expert insights on

December 24, 2025

219 – FDA PreCheck and the Future of Inspections: PAI to Pre-Readiness

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh is joined by Ben Locwin to break down what’s changing in FDA pre-approval and pre-license inspections—and why the

December 17, 2025

218 – ICH Q13: Continuous Manufacturing EXPLAINED (Batch vs. Continuous)

In this short episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh breaks down ICH Q13 and what “continuous manufacturing” actually means. He compares batch vs. continuous, explains how a

December 10, 2025

217 – 5 Fixable Problems Holding Back Drug–Device Programs

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh addresses five significant quality issues in the combination product space. This episode provides practical insights and strategies for

December 3, 2025

216 – How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O’Rourke

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh speaks with Steven O'Rourke, regulatory strategist and founder of Clarifi, a consultancy helping MedTech, biotech, and novel food

November 26, 2025

215 – Why Aren’t Technical People Leading Drug-Device Audits?

In this episode of Let’s Combinate, Subhi Saadeh breaks down why more engineers in pharma, medical devices, and combination products should seriously consider becoming auditors. Sparked by a question at

November 19, 2025

214 – The Best 5 Certifications for ANY Quality Career Path (CQE, Green Belt, CQA & More)

In this episode of Let's Combinate: Drugs + Devices host Subhi Saadeh welcomes back Andy Robertson, founder of CQE Academy. Andy shares his transformative journey involving CQE certification and how

November 12, 2025

213 – From Generic Underdog to Billion‑Dollar Exit: How Usman Ahmed Built & Sold a Sterile Injectable Site

What happens when you go all in on a generic injectable that no one else wants, and it turns into a one hundred million dollar product in the first year?

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.